Sarah Fahle

Head of Research Impact

UK Health Security Agency

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Sarah Fahle is the Head of Research Impact at the UK Health Security Agency. Her research focuses on genetic prediction models related to Alzheimer's disease, pancreatic ductal adenocarcinoma, and prostate cancer biomarkers. Additionally, she investigates the efficiency and safety of blood donation processes and the communication of polygenic risk scores in public involvement. Her work contributes significantly to the understanding of genetic associations with various health conditions.

Articles (9)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Lois Kim

University of Cambridge

UNITED KINGDOM

View details

Philippe Gilchrist

Macquarie University

AUSTRALIA

View details

Shuai Liu

University of Hawai'i System

UNITED STATES

View details

Eamonn Ferguson

Professor of Health Psychology

University of Nottingham

UNITED KINGDOM

View details

Michael Sweeting

University of Leicester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sarah Fahle

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Associations between genetically predicted plasma protein levels and Alzheimer’s disease risk: a study using genetic prediction models

Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma

Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study

Evaluation of interventions to prevent vasovagal reactions among whole blood donors

Identification of blood protein biomarkers associated with prostate cancer risk using genetic prediction models: analysis of over 140,000 subjects

What makes a good life: using theatrical performance to enhance communication about polygenic risk scores research in patient and public involvement

Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study

Abstract 882: Associations of genetically predicted blood protein biomarkers with pancreatic ductal adenocarcinoma risk: A study using comprehensive protein genetic prediction models

ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: A Mendelian randomization study: ACE inhibition and ACE2 expression

Collaborators (5)

Lois Kim

Philippe Gilchrist

Shuai Liu

Eamonn Ferguson

Michael Sweeting

Make your next move.